Trials / Unknown
UnknownNCT03280004
Reason Evaluation of Initial Treatment Failure in Patients With CAP
Reason Evaluation of Initial Treatment Failure in Patients With Community Acquired Pneumonia
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 314 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research is to evaluate the effect of different antibiotics (Moxifloxacin Hydrochloride and Sodium Chloride Injection vs. β-lactam antibiotics for injection +/- Azithromycin for Injection) on the early deterioration or progression (\<72 h of treatment) of community acquired pneumonia and to study the effect of the early deterioration or progression on the prognosis of community acquired pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin Hydrochloride and Sodium Chloride Injection | Moxifloxacin group will be given Moxifloxacin Hydrochloride and Sodium Chloride Injection and β-lactams group will be given β-lactam antibiotics for injection +/- Azithromycin for Injection. |
Timeline
- Start date
- 2017-11-20
- Primary completion
- 2019-08-31
- Completion
- 2019-11-30
- First posted
- 2017-09-12
- Last updated
- 2019-04-29
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03280004. Inclusion in this directory is not an endorsement.